• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes.在原代人肝细胞中消除诱导多能干细胞的肝细胞选择培养基。
World J Methodol. 2015 Sep 26;5(3):108-14. doi: 10.5662/wjm.v5.i3.108.
2
Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine.在缺乏葡萄糖和精氨酸的培养基中,原代人肝细胞的存活和诱导多能干细胞的死亡。
PLoS One. 2013 Aug 14;8(8):e71897. doi: 10.1371/journal.pone.0071897. eCollection 2013.
3
An Optimal Medium Supplementation Regimen for Initiation of Hepatocyte Differentiation in Human Induced Pluripotent Stem Cells.一种用于启动人诱导多能干细胞肝细胞分化的最佳培养基补充方案。
J Cell Biochem. 2015 Aug;116(8):1479-89. doi: 10.1002/jcb.25139.
4
Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine.在缺乏葡萄糖和精氨酸的培养基中,肝癌细胞与人类脐静脉血管内皮细胞共培养时的细胞死亡。
Oncol Lett. 2017 Jan;13(1):258-262. doi: 10.3892/ol.2016.5454. Epub 2016 Nov 30.
5
Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine.在不含葡萄糖和精氨酸,但含有半乳糖和鸟氨酸的培养基中培养的肝癌细胞、胰腺癌细胞和胃癌细胞的增殖和运动能力。
Oncol Lett. 2017 Mar;13(3):1276-1280. doi: 10.3892/ol.2017.5568. Epub 2017 Jan 4.
6
Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine.在不含葡萄糖、丙酮酸、精氨酸和酪氨酸的培养基中从小鼠胚胎干细胞富集得到的肝母细胞样细胞。
Cell Tissue Res. 2008 Jul;333(1):17-27. doi: 10.1007/s00441-008-0618-4. Epub 2008 May 14.
7
2‑Deoxy‑D‑glucose initiates hepatocyte differentiation in human induced pluripotent stem cells.2-脱氧-D-葡萄糖可诱导人诱导多能干细胞向肝细胞分化。
Mol Med Rep. 2017 May;15(5):3083-3087. doi: 10.3892/mmr.2017.6405. Epub 2017 Mar 28.
8
Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases.人诱导多能干细胞衍生的具有成熟特征和代谢疾病建模潜力的肝细胞的鉴定。
Int J Mol Sci. 2020 Jan 11;21(2):469. doi: 10.3390/ijms21020469.
9
Differentiation of human induced pluripotent stem cells in William's E initiation medium supplemented with 3‑bromopyruvate and 2‑deoxy‑d‑glucose.在添加了3-溴丙酮酸和2-脱氧-D-葡萄糖的威廉姆斯E起始培养基中诱导人诱导多能干细胞分化。
Mol Med Rep. 2017 Jun;15(6):3719-3723. doi: 10.3892/mmr.2017.6474. Epub 2017 Apr 12.
10
Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment.在威廉姆斯E培养基中培养后经肝细胞分化诱导剂处理,人诱导多能干细胞向肝细胞样细胞分化的存活率提高及分化起始
PLoS One. 2016 Apr 13;11(4):e0153435. doi: 10.1371/journal.pone.0153435. eCollection 2016.

引用本文的文献

1
Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.简明综述:肝脏再生医学:从肝细胞移植到生物人工肝和生物工程移植物
Stem Cells. 2017 Jan;35(1):42-50. doi: 10.1002/stem.2500. Epub 2016 Oct 2.
2
Enrichment of Pluripotent Stem Cell-Derived Hepatocyte-Like Cells by Ammonia Treatment.通过氨处理富集多能干细胞衍生的类肝细胞
PLoS One. 2016 Sep 15;11(9):e0162693. doi: 10.1371/journal.pone.0162693. eCollection 2016.

本文引用的文献

1
An Optimal Medium Supplementation Regimen for Initiation of Hepatocyte Differentiation in Human Induced Pluripotent Stem Cells.一种用于启动人诱导多能干细胞肝细胞分化的最佳培养基补充方案。
J Cell Biochem. 2015 Aug;116(8):1479-89. doi: 10.1002/jcb.25139.
2
A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.一种用于人多能干细胞衍生心肌细胞的具有代谢纯化功能的大规模悬浮培养系统。
Stem Cells Transl Med. 2014 Dec;3(12):1473-83. doi: 10.5966/sctm.2014-0072. Epub 2014 Oct 29.
3
Selective culture method for hepatocyte-like cells differentiated from human induced pluripotent stem cells.人诱导多能干细胞分化的肝细胞样细胞的选择性培养方法。
Drug Metab Pharmacokinet. 2014;29(5):407-13. doi: 10.2133/dmpk.dmpk-14-rg-022. Epub 2014 Apr 29.
4
Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.精氨酸代琥珀酸合成酶缺乏症患者的显著肝脏受累。
J Pediatr. 2014 Apr;164(4):720-725.e6. doi: 10.1016/j.jpeds.2013.12.024. Epub 2014 Jan 30.
5
Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine.在缺乏葡萄糖和精氨酸的培养基中,原代人肝细胞的存活和诱导多能干细胞的死亡。
PLoS One. 2013 Aug 14;8(8):e71897. doi: 10.1371/journal.pone.0071897. eCollection 2013.
6
Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells.慢病毒载体介导的多能干细胞胸苷激酶表达可去除致瘤细胞。
PLoS One. 2013 Jul 30;8(7):e70543. doi: 10.1371/journal.pone.0070543. Print 2013.
7
Metabolome and metaboproteome remodeling in nuclear reprogramming.在核重编程中代谢组和代谢蛋白质组的重塑。
Cell Cycle. 2013 Aug 1;12(15):2355-65. doi: 10.4161/cc.25509. Epub 2013 Jul 8.
8
Vascularized and functional human liver from an iPSC-derived organ bud transplant.源自 iPSC 衍生类器官芽移植的血管化和功能性人肝。
Nature. 2013 Jul 25;499(7459):481-4. doi: 10.1038/nature12271. Epub 2013 Jul 3.
9
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes.独特的代谢流可实现大规模纯化鼠和人多能干细胞来源的心肌细胞。
Cell Stem Cell. 2013 Jan 3;12(1):127-37. doi: 10.1016/j.stem.2012.09.013. Epub 2012 Nov 15.
10
Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.通过移植不含重编程因子c-Myc的诱导多能干细胞改善四氯化碳诱导的急性肝衰竭
Int J Mol Sci. 2012;13(3):3598-3617. doi: 10.3390/ijms13033598. Epub 2012 Mar 16.

在原代人肝细胞中消除诱导多能干细胞的肝细胞选择培养基。

Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes.

作者信息

Tomizawa Minoru, Shinozaki Fuminobu, Motoyoshi Yasufumi, Sugiyama Takao, Yamamoto Shigenori, Ishige Naoki

机构信息

Minoru Tomizawa, Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Chiba 284-0003, Japan.

出版信息

World J Methodol. 2015 Sep 26;5(3):108-14. doi: 10.5662/wjm.v5.i3.108.

DOI:10.5662/wjm.v5.i3.108
PMID:26413482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4572022/
Abstract

Hepatic insufficiency is a fatal liver disease with a significant decrease in functioning hepatocytes. If hepatocytes could be generated from human induced pluripotent stem (hiPS) cells and transplanted into patients with hepatic insufficiency, the disease may become curable. However, a major limitation to this therapeutic strategy is due to the tumorigenicity of hiPS cells and their ability to form cancer. Current methods for eliminating unwanted hiPS cells use genetic manipulation or reagents that are potentially hazardous for hepatocytes; therefore, revised methods are necessary and anticipated. Glucose and arginine are essential cell culture medium ingredients for the survival of most cells, including hiPS cells. However, hepatocytes can produce its own glucose and arginine through galactokinase and ornithine transcarbamylase, respectively. Therefore, it was hypothesized that unwanted hiPS cells could be eliminated in a medium without glucose and arginine, and supplemented with galactose and ornithine instead. This modified medium has been established as hepatocyte selection medium (HSM). So far, attempts to generate a pure colony of mature hepatocytes from hiPS cells have not been successful. After establishment of co-culture in HSM, primary human hepatocytes survive while hiPS cells die within three days. Our latest results regarding a modification of HSM will be introduced in this manuscript.

摘要

肝衰竭是一种致命的肝脏疾病,其功能性肝细胞显著减少。如果能够从人诱导多能干细胞(hiPS细胞)生成肝细胞并移植到肝衰竭患者体内,该疾病或许有望治愈。然而,这一治疗策略的一个主要限制在于hiPS细胞的致瘤性及其形成肿瘤的能力。目前消除不需要的hiPS细胞的方法使用的是对肝细胞有潜在危害的基因操作或试剂;因此,需要并期待改进的方法。葡萄糖和精氨酸是包括hiPS细胞在内的大多数细胞存活所必需的细胞培养基成分。然而,肝细胞可以分别通过半乳糖激酶和鸟氨酸转氨甲酰酶产生自身的葡萄糖和精氨酸。因此,有人提出可以在不含葡萄糖和精氨酸、而是添加半乳糖和鸟氨酸的培养基中消除不需要的hiPS细胞。这种改良培养基已被确立为肝细胞选择培养基(HSM)。到目前为止,从hiPS细胞生成成熟肝细胞纯集落的尝试尚未成功。在HSM中建立共培养后,原代人肝细胞存活,而hiPS细胞在三天内死亡。本文将介绍我们关于HSM改良的最新结果。